Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Hackett

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Sexual Medicine Reviews|February 27, 2019
Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic SyndromeGeoffrey Hackett
Sexual Medicine Reviews|March 26, 2017
The Graham Jackson Memorial Lecture ISSM 2016-"The Man Who Knew Too Much": Time to Recognize Erectile Dysfunction and Low Testosterone as Independent Risk Factors for Cardiovascular DiseaseGeoffrey Hackett
BMJ (Clinical Research Ed.)|December 4, 2014
Testosterone replacement therapy and cardiovascular eventsGeoffrey Hackett
Therapeutic Advances in Urology|April 2, 2016
An update on the role of testosterone replacement therapy in the management of hypogonadismGeoffrey Hackett
The World Journal of Men'S Health|August 7, 2018
Type 2 Diabetes and Testosterone TherapyGeoffrey Hackett
Asian Journal of Andrology|September 25, 2014
Commentary on "Late-onset hypogonadism - beyond testosterone"Geoffrey Hackett
The World Journal of Men'S Health|May 8, 2020
Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?Geoffrey Hackett
Current Diabetes Reports|November 8, 2008
Management of erectile dysfunction in diabetes: an update for 2008David Price, Geoffrey Hackett
International Journal of Clinical Practice|January 31, 2018
Erectile dysfunction and testosterone deficiency as cardiovascular risk factors?Geoffrey Hackett, Michael Kirby
Annals of Internal Medicine|April 3, 2013
Effects of testosterone replacement on response to sildenafil citrateAllen D Seftel, Geoffrey Hackett
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Sexual Medicine Reviews|February 27, 2019
Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic SyndromeGeoffrey Hackett
Sexual Medicine Reviews|March 26, 2017
The Graham Jackson Memorial Lecture ISSM 2016-"The Man Who Knew Too Much": Time to Recognize Erectile Dysfunction and Low Testosterone as Independent Risk Factors for Cardiovascular DiseaseGeoffrey Hackett
BMJ (Clinical Research Ed.)|December 4, 2014
Testosterone replacement therapy and cardiovascular eventsGeoffrey Hackett
Therapeutic Advances in Urology|April 2, 2016
An update on the role of testosterone replacement therapy in the management of hypogonadismGeoffrey Hackett
The World Journal of Men'S Health|August 7, 2018
Type 2 Diabetes and Testosterone TherapyGeoffrey Hackett
Asian Journal of Andrology|September 25, 2014
Commentary on "Late-onset hypogonadism - beyond testosterone"Geoffrey Hackett
The World Journal of Men'S Health|May 8, 2020
Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?Geoffrey Hackett
Current Diabetes Reports|November 8, 2008
Management of erectile dysfunction in diabetes: an update for 2008David Price, Geoffrey Hackett
International Journal of Clinical Practice|January 31, 2018
Erectile dysfunction and testosterone deficiency as cardiovascular risk factors?Geoffrey Hackett, Michael Kirby
Annals of Internal Medicine|April 3, 2013
Effects of testosterone replacement on response to sildenafil citrateAllen D Seftel, Geoffrey Hackett
Pageof 4